arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

SPRUCE BIOSCIENCES, INC.

SPRB

$46.63 ▲ +0.09 (+0.19%) at close

8 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Neutral

auto_awesome

Analytical Summary

SPRUCE BIOSCIENCES, INC. shows mixed fundamentals. On the positive side, Debt to Equity remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $35.7M

Dividend Yield —

Revenue Growth N/M

Op. Margin —

ROIC -67.8% ↗

FCF / Share $-43.47 ↘

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity 0.00

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-38.97M

↑ +26.5% —

FCF / Share Free cash flow per share

$-43.47

↓ -3105.5% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	N/M	-51.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-742%)	—	—	—	—	—	—
EPS Growth YoY (%)	-3840.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-4.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	36.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-8.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	26.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-10.7% Weak ↑ Weak Improving Year-over-year change in net income	-3.8% Weak ↑ Weak Improving Year-over-year change in net income	-9.2% Weak ↑ Weak Improving Year-over-year change in net income	-43.2% Weak Weak Year-over-year change in net income	-125.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-3105.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	-56.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	51.2% Excellent Excellent Year-over-year change in free cash flow	-15.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Profit Margin (%) (%)	—	—	-475.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4058%)	—	—	—	—	—
FCF Margin (%) (%)	—	—	-329.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-67.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-144.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	37.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-68.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-124.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-55.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-279.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-91.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-711%)	-184.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1327%)	-62.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-518%)	-67.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-550%)	-38.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-353%)	-19.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-232%)	42.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+185%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.05x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	-0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-117%)	—
Interest Coverage (x)	-405.70x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-182.90x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-107.65x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-112.58x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-121.93x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-91.07x Weak Weak Operating income divided by interest expense Optimal: > 5x	-201.65x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-48.91M	$-36.91M	$-92.63M	$-21.19M	$-37.87M	$-152.67M	$-731.00K	—
Debt / EBITDA (x)	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.03x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.24x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.00	$0.12	$0.26	$0.00	—	—	—	—
Basic EPS, GAAP (USD)	$-50.83	$-1.29	$-1.24	$-1.96	$-1.81	—	—	—
Free Cash Flow per Share (USD)	$-43.47	$-1.36	$-0.86	$-1.77	$-1.54	—	—	—
Book Value per Share (USD)	$30.99	$0.68	$1.86	$2.90	$4.74	$6.42	$-40.08	—
Tangible Book Value per Share (USD)	$30.99	$0.68	$1.86	$2.90	$4.74	$6.42	$-40.08	—
Basic Weighted Avg Shares (shares)	766,598	41.26M	38.51M	23.53M	23.36M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$42.03M	$28.96M	$77.72M	$71.16M	$83.02M	$150.63M	$349.00K	—
LT Debt (USD)	$0.00	$1.84M	$3.71M	$3.29M	$4.88M	$4.48M	$3.19M	—
Total Equity (USD)	$42.52M	$28.82M	$76.51M	$68.49M	$111.37M	$149.43M	$-30.64M	$-17.80M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$4.91M	$10.09M	$0.00	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	$36.00K	$12.00K	—
Net Income, GAAP (USD)	$-38.97M	$-53.04M	$-47.92M	$-46.18M	$-42.29M	$-29.54M	$-13.09M	—
Operating Cash Flow (USD)	$-33.33M	$-55.96M	$-33.27M	$-41.68M	$-35.88M	$-27.52M	$-12.62M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

SPRUCE BIOSCIENCES, INC.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SPRB with peers